Proactive Investors - Run By Investors For Investors

HekaBio CEO says Orgenesis taken 'great steps' to solve biotech manufacturing cost problem

HekaBio CEO Robert Claar sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. 

The Japan based company targets innovations in oncology, autoimmune/inflammation and neurodegenerative disease that have a high potential for significant therapeutic benefit and healthcare cost savings.

View full ORGS profile View Profile

Orgenesis Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use